77 related articles for article (PubMed ID: 10406354)
21. Bullous pemphigoid in late childhood successfully treated with mycophenolate mofetil as an adjuvant therapy.
Fox JC; Kenkare S; Petronic-Rosic V; Soltani K; Sethi A
Pediatr Dermatol; 2010; 27(5):537-9. PubMed ID: 20807355
[TBL] [Abstract][Full Text] [Related]
22. Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases.
Gelber AC; Nousari HC; Wigley FM
J Rheumatol; 2000 Jun; 27(6):1542-5. PubMed ID: 10852287
[TBL] [Abstract][Full Text] [Related]
23. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation.
Hale MD; Nicholls AJ; Bullingham RE; Hené R; Hoitsma A; Squifflet JP; Weimar W; Vanrenterghem Y; Van de Woude FJ; Verpooten GA
Clin Pharmacol Ther; 1998 Dec; 64(6):672-83. PubMed ID: 9871432
[TBL] [Abstract][Full Text] [Related]
24. Treatment of anti-laminin γ1 pemphigoid with mycophenolate mofetil.
Gawaz A; Metzler G; Hertl M; Hashimoto T; Schaller M
J Dtsch Dermatol Ges; 2015 Jul; 13(7):696-7. PubMed ID: 26058852
[No Abstract] [Full Text] [Related]
25. Trough blood concentrations in long-term treatment with mycophenolate mofetil.
Sanquer S; Breil M; Baron C; Dahmane D; Astier A; Lang P
Lancet; 1998 May; 351(9115):1557. PubMed ID: 10326544
[No Abstract] [Full Text] [Related]
26. [Mycophenolic acid: a welcome adjunct immunosuppressant after organ transplants].
van Gelder T; Gregoor PJ; Hené RJ; De Sévaux RG; Hilbrands LB
Ned Tijdschr Geneeskd; 1998 Jul; 142(27):1550-4. PubMed ID: 9763828
[TBL] [Abstract][Full Text] [Related]
27. Crohn's-like enterocolitis associated with mycophenolic acid treatment.
Dost D; van Leerdam ME; van Dekken H; Weimar W; Kuipers EJ; Bijl AH; van Gelder T
Gut; 2008 Sep; 57(9):1330. PubMed ID: 18719142
[No Abstract] [Full Text] [Related]
28. Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement.
Hanjani NM; Nousari CH
Arch Dermatol; 2002 Dec; 138(12):1616-8. PubMed ID: 12472362
[No Abstract] [Full Text] [Related]
29. Use of mycophenolate mofetil in erythema nodosum.
Boyd AS
J Am Acad Dermatol; 2002 Dec; 47(6):968-9. PubMed ID: 12451393
[No Abstract] [Full Text] [Related]
30. Perioperative Management of Biologic and Immunosuppressive Medications in Patients With Crohn's Disease.
Lightner AL
Dis Colon Rectum; 2018 Apr; 61(4):428-431. PubMed ID: 29521822
[No Abstract] [Full Text] [Related]
31. Thalidomide for Crohn's disease: high dose, low dose, or "no doze" at all?
Katz JA
Inflamm Bowel Dis; 2000 May; 6(2):152-3. PubMed ID: 10833076
[No Abstract] [Full Text] [Related]
32. Mycophenolate mofetil for dermatomyositis.
Tausche AK; Meurer M
Dermatology; 2001; 202(4):341-3. PubMed ID: 11455153
[No Abstract] [Full Text] [Related]
33. Mycophenolate Mofetil for Eosinophilic Fasciitis: A Retrospective Analysis From 3 Tertiary Care Centers.
Tkachenko E; Steuer AB; Lo K; LaChance A; Merola JF; Femia AN; Vleugels RA
JAMA Dermatol; 2020 May; 156(5):595-597. PubMed ID: 32236487
[TBL] [Abstract][Full Text] [Related]
34. Stability of mycophenolate mofetil in an extemporaneously compounded sugar-free oral liquid.
Swenson CF; Dentinger PJ; Anaizi NH
Am J Health Syst Pharm; 1999 Nov; 56(21):2224-6. PubMed ID: 10565702
[No Abstract] [Full Text] [Related]
35. Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia.
Duane DD; Monroe J; Morris RE
Mov Disord; 2000 Mar; 15(2):365-6. PubMed ID: 10752603
[No Abstract] [Full Text] [Related]
36. Recent advances in the treatment of autoimmune bullous diseases.
Takamori K
J Dermatol; 2001 Nov; 28(11):654-7. PubMed ID: 11770728
[No Abstract] [Full Text] [Related]
37. Oral SMAD7 antisense drug for Crohn's disease.
Vermeire S
N Engl J Med; 2015 Mar; 372(12):1166-7. PubMed ID: 25785975
[No Abstract] [Full Text] [Related]
38. [Efficacy and Safety of an Oral SMAD7 Antisense Drug for Active Crohn's Disease].
Seo GS
Korean J Gastroenterol; 2015 Jun; 65(6):384-5. PubMed ID: 26288865
[No Abstract] [Full Text] [Related]
39. [Good results: antisense-oligonucleotide Mongersen is in Crohn's disease].
Moskaleva M
Dtsch Med Wochenschr; 2015 May; 140(10):710-1. PubMed ID: 26171473
[No Abstract] [Full Text] [Related]
40. Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease.
Kennedy BW
N Engl J Med; 2015 Jun; 372(25):2461. PubMed ID: 26083214
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
